COO
of Scythian Biosciences (TSX.V: $SCYB.V) Talks about Treatment for
#Concussion and traumatic brain injury with #Cannabinoid-based
combination drug therapy
August
16, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source
and investor resource covering cannabis and biotech stocks issues a
podcast interview with David Schrader, Chief Operating Officer at
Scythian Biosciences Corp. (TSXV: SCYB).
Listen to the full podcast interview :
Scythian
( http://scythianbio.com/) is a research and development company
committed to finding a solution for the prevention and treatment of concussions
and traumatic brain injury with its proprietary Cannabinoid combination.
Scythian's
mission is to be the first accepted drug regimen for concussive treatment.
Scythian has recently formed a collaboration with the University of Miami and
its world renowned neuroscientific team to conduct pre-clinical and clinical
trials of its drug regimen. The
University of Miami believes that Scythian's scientific approach shows
significant promise and differs from previous approaches to treat this growing
problem. The collaboration with the
University of Miami allows access to their extensive knowledge base in the
fields of traumatic brain injury and concussions and allows for Scythian's
clinical studies to be undertaken at their world-class facilities.
Gillian
A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized
behavioral neuroscientist and expert in neurotrauma, concussion management, and
neurorehabilitation. She has extensive
experience in neurocognitive testing.
Dr. Hotz has been the co-director of University of Miami Miller School
of Medicine's Concussion Program since 1995.
Scythian
is also endorsed by Pro Football Legends and the World Boxing Association on
its mission.
About
Investorideas.com - News that Inspires Big Ideas
www.Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading
sectors.
The
Investorideas.com podcasts are also available on iTunes, Tunein, Sticher.
Spreaker.com, iHeart.com and Google Play
Music.
Subscribe to
Investorideas.com Podcast RSS:
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info:
http://www.investorideas.com/About/Disclaimer.asp.
Scythian
Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis
Investor Ideas Directory and is a paid featured cannabis company and biotech
for news, social media and PR effective August 7th for 2 months. More details -
http://www.investorideas.com/About/News/Clientspecifics.asp
Contact
Investorideas.com
800-665-0411
No comments:
Post a Comment